Micropaque Scanner (Barium Sulfate)

Barium sulfate works by providing a dense, X‑ray‑absorbing coating on the lining of the gastrointestinal tract. The high atomic number of barium particles attenuates X‑ray beams, creating a stark contrast between the lumen filled with the suspension and surrounding soft tissues, which allows clinicians to see structural details clearly on radiographic images.

The dose of Micropaque Scanner is determined by the prescribing clinician based on the specific imaging procedure, patient age, weight, and clinical indication. The healthcare professional selects the appropriate volume and concentration to achieve optimal radiographic contrast while considering patient safety.

Safety data for barium sulfate in pregnancy and lactation are limited. Use is generally reserved for situations where the diagnostic benefit outweighs potential risks. The product should only be administered to pregnant or breastfeeding patients after a careful risk‑benefit assessment by the treating physician.

To order Micropaque Scanner, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Micropaque Scanner (barium sulfate) is a high‑density, insoluble contrast medium that provides superior coating of the gastrointestinal mucosa compared with water‑soluble iodinated agents, which are often used for patients at risk of aspiration. Barium offers longer imaging windows and clearer delineation of mucosal patterns, but it should not be used when perforation is suspected.

Micropaque Scanner should be stored at ambient temperature, preferably below 25 °C. Keep the suspension in its original container, protect it from moisture, direct sunlight and extreme temperature fluctuations. Do not freeze the product, and ensure the container is tightly sealed to maintain suspension stability.

Micropaque Scanner is administered orally as a suspension. The patient drinks the prescribed volume under supervision, often after fasting. For a barium swallow, a small amount is taken; for a barium meal or enema, larger volumes are used to fill the stomach or colon, respectively. Proper positioning helps ensure even coating of the gastrointestinal tract.

Serious risks include aspiration of the suspension leading to pneumonia, barium impaction causing bowel obstruction, and rare allergic reactions such as rash, itching or swelling. In cases of gastrointestinal perforation, barium can leak into the peritoneal cavity, potentially resulting in peritonitis. Prompt medical attention is required if any of these events occur.

Micropaque Scanner should be avoided in patients with known or suspected gastrointestinal perforation, severe obstruction, or marked dysphagia. Individuals with documented hypersensitivity to barium sulfate should not receive the product. Caution is also advised for patients with severe renal impairment, pregnant or breastfeeding women unless the diagnostic benefit justifies use.